Clinical Trial Update: The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the combination of ATRA and high-dose dexamethasone as first-line treatment for adult immune thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• ATRA (all-trans retinoic acid)
• Dexamethasone (high-dose) (dexamethasone)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 2 | Status: COMPLETED